These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26850386)

  • 21. [Survival analysis on AIDS patients undergoing antiretroviral treatment, Liangshan prefecture, Sichuan province].
    Zhang G; Gong Y; Wang Q; Liao Q; Yu G; Wang J; Wang K; Yin B; Xiao L; Li Y; Liu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Dec; 35(12):1329-32. PubMed ID: 25623448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A retrospective cohort study on survival time of AIDS death cases receiving Antiretroviral Therapy and related factors].
    Hao L; Zhu X; Wang G; Lin B; Qian Y; Tao X; Hu J; Yang X; Kang D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Jun; 48(6):466-70. PubMed ID: 25219434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative analysis of outpatient costs in HIV treatment programs.
    Sarti FM; Nishijima M; Campino AC; Cyrillo DC
    Rev Assoc Med Bras (1992); 2012; 58(5):561-7. PubMed ID: 23090227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological outcomes of Tenofovir versus Zidovudine-based regimens among people living with HIV/AIDS: a two years retrospective cohort study.
    Ayele T; Jarso H; Mamo G
    AIDS Res Ther; 2017 Feb; 14(1):5. PubMed ID: 28143541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare utilization of patients accessing an African national treatment program.
    Harling G; Orrell C; Wood R
    BMC Health Serv Res; 2007 Jun; 7():80. PubMed ID: 17555564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
    Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches to antiretroviral therapy in China.
    Gilliam BL; Redfield RR
    Cell Res; 2005; 15(11-12):895-902. PubMed ID: 16354566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Survival analysis of the AIDS patients under 14 years of age and receiving antiretroviral treatment in Henan province from 2003 to 2014].
    Sun D; Yang W; Ma Y; Wang Q; Liu J; Fan P; Li N; Zhu Q; Wang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Aug; 49(8):700-4. PubMed ID: 26733028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Key quality indicators of the China Comprehensive AIDS Response 2008 - 2011 Program].
    Wu D; Zhang H; Yao XL; Cui Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Dec; 46(12):1095-8. PubMed ID: 23363966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
    Ni M; Chen X; Hu X; Ma Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of co-trimoxazole prophylaxis used for AIDS patients under anti-retroviral therapy].
    Yang W; Liang Y; Li J; Ma Y; Li N; Sun D; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):689-94. PubMed ID: 25174473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
    Sun J; Liu L; Shen J; Chen P; Lu H
    BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years.
    Zhou HY; Zheng YH; Zhang CY; Chen J; He Y; Ding PP; Li H
    Viral Immunol; 2007; 20(1):180-7. PubMed ID: 17425432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [GeSIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2014)].
    ;
    Enferm Infecc Microbiol Clin; 2014; 32(7):446.e1-42. PubMed ID: 24953253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa.
    Shoko C; Chikobvu D
    Theor Biol Med Model; 2018 Jul; 15(1):10. PubMed ID: 30008270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Survival time and related influencing factors of AIDS patients in Liangshan prefecture, Sichuan province, during 2008-2013].
    Deng L; Liu Z; Zhang S; Dou Z; Wang Q; Ma Y; Gong Y; Yu G; Wang J; Yu H; Miao F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jun; 36(6):569-75. PubMed ID: 26564626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
    Sungkanuparph S; Chakriyanuyok T; Butthum B
    J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
    Blasco AJ; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Llibre JM; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):283-93. PubMed ID: 22525829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.